Migraine
📧 Sign up to get email alerts when something new happens for Migraine.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-05-27FDA Approved: TOPIRAMATE — Original Application (Advagen Pharma Ltd)
FDA approved the original ANDA for Topiramate by Advagen Pharma Ltd, providing a generic version of the anticonvulsant. The drug is indicate…
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events in Adult Participants With Migraine [Phase 3]
A Phase 3 clinical trial compares oral atogepant with oral topiramate in adults with migraine to assess adverse events. The study is current…
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: International Headache Registry Study
An international headache registry study is currently recruiting, sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang Univ…
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: Does Nerve Block + Oral Dexamethasone Reduce Recurrence of Headache Within 72 Hrs? [EARLY_Phase 1]
An early-phase trial (Phase 1) evaluating whether a nerve block plus oral dexamethasone reduces migraine headache recurrence within 72 hours…
-
CLINICAL_TRIALS trial_result · 2025-05-16Clinical Trial Update: Sphenopalatine Block Versus BOTOX in Management of Chronic Migraine [NA]
Clinical trial comparing sphenopalatine block versus BOTOX for chronic migraine; the study is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-05-16Clinical Trial Update: Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic Migraine [Phase 3]
Phase 3 clinical trial evaluating adding oral atogepant to onabotulinumtoxinA (Botox) in adults with chronic migraine to assess adverse even…
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: BOTOX® vs. XEOMIN® for Chronic Migraine [Phase 3]
A Phase 3 trial is evaluating head-to-head efficacy of Botox (onabotulinumtoxinA) versus XEOMIN (incobotulinumtoxinA) for chronic migraine; …
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: Idebenone for the Preventive Treatment of Migraine [Phase 3]
Phase 3 trial evaluating idebenone for preventive treatment of migraines is currently recruiting.
-
FDA approval · 2025-05-14FDA Approved: BREKIYA — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Brekiya (dihydroergotamine mesylate) from Amneal Pharmaceuticals in an original application for the acute treatment of migraine…
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Efficacy and Safety of Oral NBP Soft Capsules for the Prevention of Episode Migraine Attacks in Adult Migraine Patients [NA]
Clinical trial registry entry evaluating the efficacy and safety of NBP Soft Capsules for prevention of migraine episodes in adults; the tri…
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Effectiveness of Tai Chi and Acupuncture on Migraine Attack Prevention and Brain White Matter Changes: A Non-Inferiority RCT [NA]
A non-inferiority randomized trial from The Hong Kong Polytechnic University investigates whether Tai Chi and acupuncture can prevent migrai…
-
CLINICAL_TRIALS trial_result · 2025-05-11Clinical Trial Update: Study of Efficacy and Safety of Erenumab in Adult Chronic Migraine Patients [Phase 3]
A Phase 3 trial evaluating erenumab for adult chronic migraine has completed and posted results. The update summarizes the efficacy and safe…
-
CLINICAL_TRIALS trial_result · 2025-05-11Clinical Trial Update: Uric Acid Levels and Migraine in Children
A completed clinical trial investigated the relationship between uric acid levels and migraine in children.
-
FDA approval · 2025-05-09FDA Approved: ASCOMP WITH CODEINE — Supplemental Application (LGM PHARMA SOLUTIONS, LLC)
The FDA approved a supplemental application for ASCOMP WITH CODEINE, a combination product of butalbital, aspirin, caffeine, and codeine pho…
-
CLINICAL_TRIALS research · 2025-05-09Clinical Trial Update: A Study of Wearable Devices to Predict Migraines [NA]
A Mayo Clinic-sponsored clinical trial is evaluating wearable devices to predict migraine attacks. Enrollment is currently by invitation.
-
CLINICAL_TRIALS trial_result · 2025-05-08Clinical Trial Update: Intramuscular Electrical Stimulation for the Treatment of Trigger Points in Patients With Migraine [NA]
A completed clinical trial evaluating intramuscular electrical stimulation of trigger points for chronic migraine has finished. The availabl…
-
CLINICAL_TRIALS withdrawal · 2025-05-08Clinical Trial Update: Study of Wireless Nerve Stimulation in the Treatment of Chronic Migraine [Phase 3]
A Phase 3 trial evaluating wireless nerve stimulation for chronic migraine has been withdrawn.
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: Establishment of a Clinical and Prognostic Follow-up Cohort of Migraine Patients With Patent Foramen Ovale
A clinical trial update describing the establishment of a follow-up cohort to study migraine patients with patent foramen ovale at Peking Un…
-
FDA approval · 2025-04-30FDA Approved: ATZUMI — Original Application (Satsuma Pharmaceuticals, Inc.)
FDA approved ATZUMI (dihydroergotamine mesylate) from Satsuma Pharmaceuticals in NDA217901 for the acute treatment of migraine.
-
CLINICAL_TRIALS research · 2025-04-25Clinical Trial Update: Clinical and Neurophysiological Effects of tDCS to Visual and Motor Cortex in Migraine [NA]
An update on a clinical trial evaluating the neurophysiological effects of transcranial direct current stimulation to the visual and motor c…
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: 0.5% Bupivacaine Lower Cervical Intramuscular Injection vs IV Medications for Headache Treatment [Phase 3]
Phase 3 trial investigating 0.5% bupivacaine injected into the lower cervical muscles for headache treatment, comparing with intravenous med…
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: High-Density EEG-MEG-wearable EEG: Comparison of Quantitative Electroencephalographic Indicators as Neurophysiological Markers of Effectiveness of Mindfulness Therapy in Addition to Standard Treatment in Patients With High-frequency Episodic Migraine
A clinical trial evaluating quantitative EEG/MEG wearable indicators and mindfulness therapy as an adjunct to standard treatment for high-fr…
-
CLINICAL_TRIALS research · 2025-04-20Clinical Trial Update: Ketamine and Lidocaine Infusion in Refractory Chronic Migraine [EARLY_Phase 1]
This early Phase 1 trial from Assiut University is evaluating ketamine and lidocaine infusion for refractory chronic migraine. The study is …
-
CLINICAL_TRIALS trial_result · 2025-04-18Clinical Trial Update: Introvision for Migraine and Headaches [NA]
A completed clinical trial of Introvision for migraine and chronic migraine with results posted.
-
CLINICAL_TRIALS trial_result · 2025-04-16Clinical Trial Update: A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of Age [Phase 3]
A Phase 3 pediatric trial of fremanezumab for preventing episodic migraine in ages 6 to 17 has completed and posted results.